Amneal Pharmaceuticals, Inc. (AMRX) ownership: Top institutional holder: BlackRock, Inc. ($304.77M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 24519192.00 | $304.77M | 2026-03-31 |
| VANGUARD GROUP INC | 17907815.00 | $225.64M | 2025-12-31 |
| TPG GP A, LLC | 12328767.00 | $153.25M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11324933.00 | $140.77M | 2026-03-31 |
| Rubric Capital Management LP | 11037589.00 | $137.20M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7585034.00 | $94.28M | 2026-03-31 |
| STATE STREET CORP | 6794702.00 | $84.46M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 5690586.00 | $70.72M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-11 | |
| Sell | null | 2026-05-11 | |
| Sell | null | 2026-05-07 | |
| Sell | null | 2026-05-07 | |
| Sell | null | 2026-05-07 | |
| Sell | null | 2026-05-07 | |
| Sell | null | 2026-05-07 | |
| Sell | null | 2026-05-07 |
Back to AMRX overview · AMRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.